Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Gynecologic Neoplasms
17. May 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 16439
Articles 1 - 20 / 328769
Latent profiles of parenting concerns and influencing factors among Chinese breast cancer mothers: a mixed-methods study.
Eur J Oncol Nurs
Zhang YH, Xu Q, Cao ZY, Ding M, Wang ZZ, Hong JF.
PMID: 42143437 [PubMed - as supplied by publisher]
Predictors of pathologic complete response in triple‑negative breast cancer treated with neoadjuvant chemotherapy: a systematic review and meta-analysis.
Clin Exp Med
Li X, Peng K, Li Q.
PMID: 42143190 [PubMed - as supplied by publisher]
Pre-treatment of cabozantinib prior to hypofractionated radiotherapy increases immunomodulatory effects and tumor size reduction in a 4T1 breast cancer murine model.
Sci Rep
Keshavarz F, Kouchaki A, Soltanshahi M, Jaafari MR, Mafi AR, Shabani M, Jalali SA.
PMID: 42143109 [PubMed - as supplied by publisher]
Betulinic acid is associated with miR-21 modulation, apoptosis and redox changes in breast cancer cells: an in vitro and in silico study.
Sci Rep
Mahmoud MA, Abdo H, Mekky M, Salem T, Mabrouk S, Khaled B.
PMID: 42143107 [PubMed - indexed for MEDLINE]
Circadian Rhythms as Orchestrators of Breast Cancer Metastasis: From Molecular Mechanisms to Chronotherapeutic Interventions.
Cancer Lett
Sabit H, Ghazy A, Albogami KFKM, Abdelhadi OE, Abdel-Ghany S, Arneth B.
PMID: 42142702 [PubMed - as supplied by publisher]
"Neoadjuvant trastuzumab deruxtecan for high-risk HER2-positive early breast cancer: Does the evidence support its use as a new standard-of-care?".
Eur J Cancer
Conforti F, Sala I, Pala L, Bendoni M, Canzian J, Tinterri B, De Pas T, Locatelli M, Bagnardi V, Gelber R.
PMID: 42142430 [PubMed - as supplied by publisher]
An exploratory study on exposure to bisphenol A analogues and breast cancer risk.
Environ Int
Siddique S, Habibagahi A, Marro L, Bouraoui I, Kubwabo C, Harris SA.
PMID: 42142421 [PubMed - as supplied by publisher]
Increasing efficiency in the ACR Digital Mammography QC Manual's DBT Z-resolution evaluation.
J Appl Clin Med Phys
Fisher RF, Bevins NB, Hulme KW, Schaeffer C.
PMID: 42142398 [PubMed - indexed for MEDLINE]
Primary tumour resection reduces the risk of major local morbidity in de novo stage IV breast cancer: secondary data analysis from the JCOG1017 randomized controlled trial.
Br J Surg
Ishitobi M, Tanaka K, Shimomura A, Yamanaka T, Tsukioki T, Iwata H, Hara F, Fujisawa T, Sasaki K, Kajikawa R, Sakai T, Sagara Y, Shigematsu H, Ozaki Y, Nozawa K, Sudo K, Naito Y, Terata K, Ishiba T, Fukuda H, Shien T.
PMID: 42142363 [PubMed - as supplied by publisher]
Association of CA12 with calcification in ER+/HER-2 negative breast cancer.
Discov Oncol
Zhu Y, Du Q, Ma Y, Xu N, Luo Y, Liu D.
PMID: 42142233 [PubMed - as supplied by publisher]
Effects of yoga on depressive symptoms in breast cancer patients: a meta-analysis of randomized controlled trials.
Support Care Cancer
Li Y, Wang J, Wang Z, Yun J, Yang Y, Yang X, Xiao X, Ren C.
PMID: 42142147 [PubMed - indexed for MEDLINE]
Machine learning-driven integration of multi-omics data uncovers methylation-dependent molecular signatures for luminal A and B breast cancer subtypes.
Epigenomics
Elsisi M, Maged M, Elhwary M, Abdallah K, Alaa-Eldin H, K Elsherif A.
PMID: 42142024 [PubMed - as supplied by publisher]
Association Between Dietary/Supplementary Calcium Intake and Risk of Breast Cancer: A Systematic Review and Meta-Analysis of Cohort Studies.
Nutr Cancer
Karimi M, Rabiee R, Babaeian Amini N, Valizadeh F, Ahmadzadeh M, Asbaghi O, Amirpour M, Davoodi SH, Larijani B.
PMID: 42141946 [PubMed - as supplied by publisher]
Twenty-year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer.
CA Cancer J Clin
Kaidar-Person O, Weltens CG, Fortpied C, Scheijmans LJEE, Kirkove CY, Budach V, Peignaux-Casasnovas K, Valli M, Peters M, van der Leij F, Rivera S, Weidner N, van den Bongard DHJG, Linsenmeier C, Abdah-Bortnyak R, Hosni S, Koiter E, Engelen AM, Baten A, Champezou L, Fourquet A, Bartelink HGMM, Struikmans H, Poortmans PMP, European Organization for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups.
PMID: 42141924 [PubMed - indexed for MEDLINE]
Germline Pathogenic Variants in HER2-Positive Breast Cancer: Spectrum and Clinical Implications in a High-Risk Chinese Cohort.
Cancer Med
Zhou L, Ni M, Yang A, Zhou Q, Wang D, Dun S, Xu F, Huang J, Bi X, Xia W, Hong R, Zheng Q, Chen M, Jiang K, Tang J, Wang X, Yuan Z, Wang S, Shi Y, Wang F, An X.
PMID: 42141527 [PubMed - indexed for MEDLINE]
Early, delayed, or combined contrast-enhanced mammography for detecting residual disease after neoadjuvant chemotherapy in breast cancer.
Eur Radiol
Bellini C, Bicchierai G, Maiello C, Amato F, de Benedetto D, di Naro F, Vidali S, Tonelli P, Vanzi E, Boeri C, Visani L, Vezzosi V, Orzalesi L, Susini T, Miele V, Nori J.
PMID: 42141291 [PubMed - as supplied by publisher]
Study on the synergistic efficacy and mechanism of CD24 silencing combined with trastuzumab in HER2-positive breast cancer.
J Mol Histol
Lu Y, Zhou X, Gao Y, Zhu Z, Deng B, Lv W, Fu Z, Ding H, Zhong L.
PMID: 42141178 [PubMed - indexed for MEDLINE]
Feasibility study of the Four-Session Cognitive-Behavioral Therapy-based Psychological Intervention Program for women with HER2-positive metastatic breast cancer.
Support Care Cancer
Szekeres T, Balázs MÁ, Madarász B, Póti Z, Urbán R, Dank M, Vizin G.
PMID: 42141145 [PubMed - indexed for MEDLINE]
Expert recommendations for PIK3CA testing in HR+/HER2- locally advanced and metastatic breast cancer.
NPJ Breast Cancer
Marchiň C, Rojo F, Copson ER, Schmitt F, Bellosillo B, Fremd C.
PMID: 42140989 [PubMed - as supplied by publisher]
Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial.
Nat Commun
Garrido-Castro AC, Graham N, Li KX, Bi L, Crowdis J, Bi K, Park J, Pastorello R, Li Y, Gupta H, Kuntz T, Petry R, Pasquina LW, Patel A, Lange P, DiLullo M, Attaya V, Frey AM, Childress MA, Wesolowski R, Sinclair N, Sinclair S, Lo S, Tung N, Faggen M, Kaufman PA, Block CC, Walsh J, Toke M, Chen W, Wucherpfennig KW, Tian Y, Williams AJ, Mukhopadhyay S, Dasgupta T, Schnitt S, Cherniack AD, Barroso R, Ligibel J, Lin NU, Mittendorf EA, Tayob N, Van Allen E, Tolaney SM.
PMID: 42140950 [PubMed - as supplied by publisher]
Articles 1 - 20 / 328769
Page 1 of 16439
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy